Something remarkable is happening in Chinese biotech, and it’s happening fast. The country’s drug developers are learning to run — really run — through clinical trials and regulatory approvals. In an ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

EXCLUSIVE: More leaked PowerPoint lectures from a first-year University of Illinois Urbana-Champaign class show left-wing ideology woven into the fabric of the course. Fox News Digital obtained course ...

Venture capital firm Aditum Bio is going all-out for a new collaboration with Fosun Pharma, launching a subsidiary with the sole purpose of developing novel therapies in tandem with the Shanghai-based ...

After a year marked by dramatic ups and downs, William Blair analysts say 2026 could carry forward the industry’s current momentum—as long as strong clinical data continue to be rewarded and companies ...

This is read by an automated voice. Please report any issues or inconsistencies here. On a nippy Monday night at the Zebulon in Frogtown, a man wearing a Jason Voorhees T-shirt steps onto a ...